For decades, the United States and the United Kingdom have enjoyed a special relationship that crosses political, economic, and military lines. But, the two nations also share a similar comradery in the Life Sciences arena, and prominent biotech hubs like the BioHealth Capital Region and Philadelphia showcase that connection.
Over the past nine months, more than $7 billion in federal funding has poured into the BioHealth Capital Region aimed at the battle against COVID-19 and has shown a spotlight on the broad impact biopharma life science companies and academic institutions are making in the fight against the pandemic.
The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
The Top Biotech Companies That are Hiring – June 2020 June 9, 2020 Despite the uncertainty created by the COVID-19 pandemic, companies across the BioHealth Capital Region (BHCR) continue to [….]
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
The Top Five Life Science Companies in Maryland For Career Growth and Promotions
GSK and Montgomery College Partner on New Apprenticeship Program to Meet Growing Demands for Biomanufacturing Workforce in Maryland
GSK Expands biomanufacturing Apprenticeship Program in Maryland with Montgomery College
Secretary Kelly Schulz
This Maryland BioPharma is Preparing for Massive Growth by Showcasing its Mission, Culture and People
GSK Biopharm Site Director, Craig Malzahn addressing BioBuzz attendees at recruiting event
Leaders Discuss Top Priorities for Workforce & Infrastructure to Grow BioHealth Capital Region April 3, 2019 Scientists, engineers, life science executives, academics, government officials and other constituents recently gathered to [….]